126 related articles for article (PubMed ID: 34869110)
21. Chinese cases of early infantile epileptic encephalopathy: a novel mutation in the PCDH19 gene was proved in a mosaic male- case report.
Tan Y; Hou M; Ma S; Liu P; Xia S; Wang Y; Chen L; Chen Z
BMC Med Genet; 2018 Jun; 19(1):92. PubMed ID: 29866057
[TBL] [Abstract][Full Text] [Related]
22. De novo loss-of-function variants of ASH1L are associated with an emergent neurodevelopmental disorder.
Shen W; Krautscheid P; Rutz AM; Bayrak-Toydemir P; Dugan SL
Eur J Med Genet; 2019 Jan; 62(1):55-60. PubMed ID: 29753921
[TBL] [Abstract][Full Text] [Related]
23. [Study of
Gao ZJ; Jiang Q; Chen XL; Chen Q; Ji XN; Mao YY; Feng S; Dong JJ; Xu KM
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3426-3432. PubMed ID: 30440138
[No Abstract] [Full Text] [Related]
24. PADDAS syndrome associated with hair dysplasia caused by a de novo missense variant of PUM1.
Bonnemason-Carrere P; Morice-Picard F; Pennamen P; Arveiler B; Fergelot P; Goizet C; Hellegouarch M; Lacombe D; Plaisant C; Raclet V; Rooryck C; Lasseaux E; Trimouille A
Am J Med Genet A; 2019 Jun; 179(6):1030-1033. PubMed ID: 30903679
[TBL] [Abstract][Full Text] [Related]
25. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
26. Case Report: CNNM2 Mutations Cause Damaged Brain Development and Intractable Epilepsy in a Patient Without Hypomagnesemia.
Li X; Bao S; Wang W; Shi X; Hu Y; Li F; Zhao Q; Zheng F; Lin Z
Front Genet; 2021; 12():705734. PubMed ID: 34490037
[TBL] [Abstract][Full Text] [Related]
27. A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report.
Santoro C; Giugliano T; Bernardo P; Palladino F; Torella A; Del Vecchio Blanco F; Onore ME; Carotenuto M; Nigro V; Piluso G
BMC Neurol; 2020 Sep; 20(1):327. PubMed ID: 32873259
[TBL] [Abstract][Full Text] [Related]
28. A
Jiang M; Yang L; Wu J; Xiong F; Li J
Transl Pediatr; 2021 Jun; 10(6):1748-1754. PubMed ID: 34295791
[TBL] [Abstract][Full Text] [Related]
29. Do the exome: A case of Williams-Beuren syndrome with severe epilepsy due to a truncating de novo variant in GABRA1.
Popp B; Trollmann R; Büttner C; Caliebe A; Thiel CT; Hüffmeier U; Reis A; Zweier C
Eur J Med Genet; 2016 Oct; 59(10):549-53. PubMed ID: 27613244
[TBL] [Abstract][Full Text] [Related]
30. A
Chen Y; Liu KY; Yang ZL; Li XH; Xu R; Zhou H
Front Pediatr; 2020; 8():303. PubMed ID: 32714884
[No Abstract] [Full Text] [Related]
31. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
32. Identification of
Leonardi E; Bettella E; Pelizza MF; Aspromonte MC; Polli R; Boniver C; Sartori S; Milani D; Murgia A
Front Neurol; 2020; 11():593446. PubMed ID: 33391157
[No Abstract] [Full Text] [Related]
33. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
[TBL] [Abstract][Full Text] [Related]
34. Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature.
El Chehadeh S; Kerstjens-Frederikse WS; Thevenon J; Kuentz P; Bruel AL; Thauvin-Robinet C; Bensignor C; Dollfus H; Laugel V; Rivière JB; Duffourd Y; Bonnet C; Robert MP; Isaiko R; Straub M; Creuzot-Garcher C; Calvas P; Chassaing N; Loeys B; Reyniers E; Vandeweyer G; Kooy F; Hančárová M; Havlovicová M; Prchalová D; Sedláček Z; Gilissen C; Pfundt R; Wassink-Ruiter JSK; Faivre L
Eur J Hum Genet; 2016 Jan; 25(1):43-51. PubMed ID: 27804958
[TBL] [Abstract][Full Text] [Related]
35. Confirmation and Expansion of the Phenotype Associated with the Recurrent p.Val837Met Variant in TRPM3.
de Sainte Agathe JM; Van-Gils J; Lasseaux E; Arveiler B; Lacombe D; Pfirrmann C; Raclet V; Gaston L; Plaisant C; Aupy J; Trimouille A
Eur J Med Genet; 2020 Aug; 63(8):103942. PubMed ID: 32439617
[TBL] [Abstract][Full Text] [Related]
36. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
[TBL] [Abstract][Full Text] [Related]
37. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
38. A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.
Buchert R; Tawamie H; Smith C; Uebe S; Innes AM; Al Hallak B; Ekici AB; Sticht H; Schwarze B; Lamont RE; Parboosingh JS; Bernier FP; Abou Jamra R
Am J Hum Genet; 2014 Nov; 95(5):602-10. PubMed ID: 25439727
[TBL] [Abstract][Full Text] [Related]
39. A de novo heterozygous variant in the SON gene is associated with Zhu-Tokita-Takenouchi-Kim syndrome.
Yang L; Yang F
Mol Genet Genomic Med; 2020 Nov; 8(11):e1496. PubMed ID: 32926520
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic expansion in Zhu-Tokita-Takenouchi-Kim syndrome caused by de novo variants in the SON gene.
Slezak R; Smigiel R; Rydzanicz M; Pollak A; Kosinska J; Stawinski P; Malgorzata Sasiadek M; Ploski R
Mol Genet Genomic Med; 2020 Oct; 8(10):e1432. PubMed ID: 32705777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
